Immunohistochemical Study of Neurodegenerative Diseases
Status:
Active, not recruiting
Trial end date:
2023-04-30
Target enrollment:
Participant gender:
Summary
The subject uses cytof to analyze PBMC of sporadic AD and DLB, which is used to reveal the
differences in immune characteristics of the two diseases at the single-cell level, build
immune models for specific diseases, and define these two neurodegenerative diseases with
high precision from the level of molecular immunity. To provide basis for further study of
the immunohistochemical differences between the two diseases, and provide objective support
for clinical diagnosis and differential diagnosis.